Emcure Pharmaceuticals Q1 FY26 performance was bolstered by healthy momentum across both domestic and international markets.
Read MoreNamita Thapar
Emcure Secures Exclusive Distribution Rights for Sanofi India’s Oral Anti-diabetic Drugs
Emcure will exclusively promote and distribute Sanofi’s oral anti-diabetic drugs brands, including the widely prescribed Amaryl and Cetapin, throughout India.
Read MoreThe Bear House Expands to the Middle East with Launch on Noon, Namshi, and Amazon
The Bear House strengthens its vision to become a globally recognized affordable luxury brand and aims to build a robust omnichannel and retail presence.
Read More